Batard, E. | IICIMED

Batard, E.

Professeur – Praticien Hospitalier - Responsable de département

Publications

P308

Gut Microbes, 2026, 18, 1.

Pre-existing β-lactamase gene diversity is associated with lower risk of ESBL-producing Enterobacterales colonization in patients exposed to ceftriaxone.


https://doi.org/10.1080/19490976.2026.2627692

P307

Journal of Applied Microbiology, 2026, 137, 3, lxag041.

Evaluation of Escherichia coli as a prophylactic treatment of intestinal colonization by extended-spectrum beta-lactamase-producing E. coli in a murine model of antibiotic-induced dysbiosis.


https://doi.org/10.1093/jambio/lxag041

P277

Gut Microbes 2024, 16, 2347021.

Efficacy of an inulin-based treatment on intestinal colonization by multidrug-resistant E. coli: insight into the mechanism of action.


https://doi.org/10.1080/19490976.2024.2347021

P274

J. Appl. Microbiol. 2023, lxad223. 

Pantoprazole promotes sustained intestinal carriage of multi-drug resistant Escherichia coli in amoxicillin-treated mice.


https://doi.org/10.1093/jambio/lxad223

P259

Appl. Microbiol. 2022, 132, 2270–2279. 

In vitro and in vivo activity of new strains of Bacillus subtilis against ESBL‐producing Escherichia coli: an experimental study.


https://doi.org/10.1111/jam.15329

Autres publications scientifiques

PS34

Clin. Microbiol. Infect. 2024, 30, 1384-1407

European society of clinical microbiology and infectious diseases guidelines for antimicrobial stewardship in emergency departments (endorsed by European association of hospital pharmacists).


https://doi.org/10.1016/j.cmi.2024.05.014

Brevets

Thèse